(Q40882291)

24 September 2017

title

Tamoxifen-resistant glioma-cell sub-populations are characterized by increased migration and proliferation (English)

1 reference

24 September 2017

1 reference

M J Puchner

1

1 reference

24 September 2017

A Giese

series ordinal

2

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

International Journal of Cancer

24 September 2017

published in

1 reference

24 September 2017

volume

86

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

468-473

1 reference

Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Reversal of tamoxifen resistance of human breast carcinomas in vivo by neutralizing antibodies to transforming growth factor-beta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Interaction of tamoxifen with the multidrug resistance P-glycoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Prolonged treatment with biologic agents for malignant glioma: a case study with high dose tamoxifen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Dichotomy of astrocytoma migration and proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

The role of protein kinase C in migration of rat glioma cells from spheroid cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Acquired tamoxifen resistance in human breast cancer and reduced intra-tumoral drug concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Dissecting glioma invasion: interrelation of adhesion, migration and intercellular contacts determine the invasive phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Intravenous administration of high doses of carboplatin in multimodal treatment of high grade gliomas: a phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

The significance of heregulin in breast cancer tumor progression and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Mechanisms of tamoxifen resistance in the treatment of advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Tamoxifen and carboplatin combinational treatment of high-grade gliomas. Results of a clinical trial on newly diagnosed patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Changes in insulin-like growth factor-I receptor expression and binding protein secretion associated with tamoxifen resistance and estrogen independence in human breast cancer cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

A comparison of the relative chemosensitivity of human gliomas to tamoxifen and n-desmethyltamoxifen in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Inhibition of human malignant glioma cell motility and invasion in vitro by hypericin, a potent protein kinase C inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

ERBB2 amplification is associated with tamoxifen resistance in steroid-receptor positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

Tamoxifen circumvents the multidrug resistance in fresh human gastrointestinal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0215%2820000515%2986%3A4%3C468%3A%3AAID-IJC4%3E3.0.CO%3B2-R

10.1002/(SICI)1097-0215(20000515)86:4<468::AID-IJC4>3.0.CO;2-R

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference